Long-term efficacy and cost-effectiveness of infliximab as first-line treatment in rheumatoid arthritis: systematic review and meta-analysis
about
Long-term efficacy and cost-effectiveness of infliximab as first-line treatment in rheumatoid arthritis: systematic review and meta-analysis
description
2019 nî lūn-bûn
@nan
2019年の論文
@ja
2019年学术文章
@wuu
2019年学术文章
@zh
2019年学术文章
@zh-cn
2019年学术文章
@zh-hans
2019年学术文章
@zh-my
2019年学术文章
@zh-sg
2019年學術文章
@yue
2019年學術文章
@zh-hant
name
Long-term efficacy and cost-ef ...... matic review and meta-analysis
@en
type
label
Long-term efficacy and cost-ef ...... matic review and meta-analysis
@en
prefLabel
Long-term efficacy and cost-ef ...... matic review and meta-analysis
@en
P50
P1476
Long-term efficacy and cost-ef ...... matic review and meta-analysis
@en
P304
P356
10.1080/14737167.2019.1647104
P577
2019-08-01T00:00:00Z